AI Peptide Discovery Platform

About Koliber Biosciences

Koliber Biosciences is a private, pre-revenue biotechnology company that combines machine learning/AI expertise with deep biological domain knowledge to offer both service-based solutions and develop proprietary technology platforms. Its core assets include an AI platform for peptide drug discovery, funded by the NSF, and a genetic toolkit for engineering Lactobacillus species, funded by an NIH SBIR grant. The company's business model is hybrid, encompassing fee-for-service consulting in data science and statistics while advancing internal platform technologies with the potential for therapeutic or tool licensing.

Therapeutic Areas